New hope for pancreatic cancer: Pre-Surgery combo aims for cleaner resection
NCT ID NCT03492671
First seen Nov 01, 2025 · Last updated Jun 13, 2026 · Updated 36 times
Summary
This study is for people with pancreatic cancer that can be surgically removed. It tests whether giving chemotherapy and radiation before surgery helps surgeons remove all cancer cells more completely. About 30 adults will receive the drugs gemcitabine and nab-paclitaxel plus targeted radiation, then surgery, then more chemo. The goal is to improve long-term survival and reduce cancer return.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREAS ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Loma Linda University Health
RECRUITINGLoma Linda, California, 92354, United States
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.